Usistapide

DB12414InvestigationalSmall molecule

Usistapide has been used in trials studying the treatment of Obesity, Overweight, Metabolic Diseases, Nutrition Disorders, and Nutritional and Metabolic Diseases.

Chemical structure of Usistapide
Formula / weight
C34H31F3N2O3 · 572.628 g/mol (avg)
Code names
JNJ-16269110 · R-256918

Resolves to

Compound
UNII73YSY3U094CAS403989-79-7PubChem56842069
Structure
InChIKeyWSYALRNYQFNNGP-WJOKGBTCSA-NSMILESCOC(=O)[C@H](N1CCC(CC1)C1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C=C1)C1=CC=CC=C1
Targets
P55157MTTP

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Usistapide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In